AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 265 filers reported holding AVANOS MED INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $639 | -99.9% | 25 | -99.9% | 0.00% | -100.0% |
Q1 2023 | $864,423 | +6.1% | 29,066 | -3.5% | 0.01% | 0.0% |
Q4 2022 | $815,020 | -42.8% | 30,119 | -53.9% | 0.01% | -37.5% |
Q3 2022 | $1,424,000 | -38.4% | 65,374 | -22.7% | 0.01% | -42.9% |
Q2 2022 | $2,313,000 | -57.6% | 84,618 | -48.0% | 0.01% | -69.6% |
Q1 2022 | $5,450,000 | +133.0% | 162,692 | +141.2% | 0.05% | +109.1% |
Q4 2021 | $2,339,000 | -6.4% | 67,453 | -15.8% | 0.02% | -29.0% |
Q3 2021 | $2,499,000 | +269.7% | 80,095 | +331.0% | 0.03% | +287.5% |
Q2 2021 | $676,000 | +9.2% | 18,583 | +31.3% | 0.01% | 0.0% |
Q1 2021 | $619,000 | -64.5% | 14,150 | -62.8% | 0.01% | -66.7% |
Q4 2020 | $1,746,000 | +27.7% | 38,060 | -7.5% | 0.02% | +20.0% |
Q3 2020 | $1,367,000 | +11.6% | 41,151 | -1.2% | 0.02% | -4.8% |
Q2 2020 | $1,225,000 | +89.9% | 41,667 | +74.0% | 0.02% | +23.5% |
Q1 2020 | $645,000 | -53.5% | 23,943 | -41.8% | 0.02% | -32.0% |
Q4 2019 | $1,387,000 | +417.5% | 41,160 | +475.7% | 0.02% | +400.0% |
Q3 2019 | $268,000 | +446.9% | 7,150 | +550.0% | 0.01% | +150.0% |
Q4 2018 | $49,000 | -89.0% | 1,100 | -83.1% | 0.00% | -91.7% |
Q3 2018 | $445,000 | – | 6,496 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |